000 01401 a2200421 4500
005 20250515022636.0
264 0 _c20060502
008 200605s 0 0 eng d
022 _a1526-632X
024 7 _a10.1212/01.wnl.0000204446.82823.28
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHernán, Miguel A
245 0 0 _aNonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease.
_h[electronic resource]
260 _bNeurology
_cApr 2006
300 _a1097-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAcetaminophen
_xadverse effects
650 0 4 _aAged
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xadverse effects
650 0 4 _aAntiparkinson Agents
_xtherapeutic use
650 0 4 _aAspirin
_xadverse effects
650 0 4 _aCase-Control Studies
650 0 4 _aCohort Studies
650 0 4 _aDatabases, Factual
650 0 4 _aFamily Practice
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aMale
650 0 4 _aParkinson Disease
_xdiagnosis
650 0 4 _aSex Characteristics
650 0 4 _aTremor
650 0 4 _aUnited Kingdom
_xepidemiology
700 1 _aLogroscino, Giancarlo
700 1 _aGarcía Rodríguez, Luis A
773 0 _tNeurology
_gvol. 66
_gno. 7
_gp. 1097-9
856 4 0 _uhttps://doi.org/10.1212/01.wnl.0000204446.82823.28
_zAvailable from publisher's website
999 _c16212237
_d16212237